Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1981 Mar 7;282(6266):766–768. doi: 10.1136/bmj.282.6266.766

Patient reactions to long-term outpatient treatment with continuous subcutaneous insulin infusion.

J C Pickup, H Keen, G C Viberti, R W Bilous
PMCID: PMC1504585  PMID: 6783163

Abstract

Fourteen of the first 15 insulin-dependent diabetics to be treated in our unit by three weeks or more of outpatient continuous subcutaneous insulin infusion with a portable syringe pump completed a questionnaire about their reactions to the system. Motivation was more important to a favourable response than occupation or intelligence. Most patients thought that diabetic control was better with the pump than conventional injection treatment and several felt subjectively better. Features such as the greater flexibility of diet and insulin delivery rates during continuous subcutaneous infusion were appreciated. The most consistent adverse criticism was about the size of the device used, nearly all patients thinking that smaller and lighter infusion systems should be developed. Psychological reactions to the infusion and difficulties with interpersonal relationships were identified; these must be clearly appreciated and discussed with patients and family before and during treatment. Nine of the 14 patients said they would undertake continuous subcutaneous infusion for one year and a further two said they would do so if the infuser was smaller. These results provide guidance on future technological development of continuous subcutaneous insulin infusion and indicate that the major constraint to long-term trials of the present system is the size of the pump.

Full text

PDF
766

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Champion M. C., Shepherd G. A., Rodger N. W., Dupre J. Continuous subcutaneous infusion of insulin in the management of diabetes mellitus. Diabetes. 1980 Mar;29(3):206–212. doi: 10.2337/diab.29.3.206. [DOI] [PubMed] [Google Scholar]
  2. Pickup J. C., Keen H. Continuous subcutaneous insulin infusion: a developing tool in diabetes research. Diabetologia. 1980 Jan;18(1):1–4. doi: 10.1007/BF01228294. [DOI] [PubMed] [Google Scholar]
  3. Pickup J. C., Keen H., Parsons J. A., Alberti K. G. Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. Br Med J. 1978 Jan 28;1(6107):204–207. doi: 10.1136/bmj.1.6107.204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Pickup J. C., Keen H., Parsons J. A., Alberti K. G. Continuous subcutaneous insulin infusion:good blood glucose control for up to 4 days. Diabetologia. 1979 Jun;16(6):385–389. doi: 10.1007/BF01223159. [DOI] [PubMed] [Google Scholar]
  5. Pickup J. C., Keen H., Parsons J. A., Alberti K. G., Rowe A. S. Continuous subcutaneous insulin infusion: improved blood-glucose and intermediary-metabolite control in diabetics. Lancet. 1979 Jun 16;1(8129):1255–1257. doi: 10.1016/s0140-6736(79)92225-6. [DOI] [PubMed] [Google Scholar]
  6. Pickup J. C., Keen H., Viberti G. C., White M. C., Kohner E. M., Parsons J. A., Alberti K. G. Continuous subcutaneous insulin infusion in the treatment of diabetes mellitus. Diabetes Care. 1980 Mar-Apr;3(2):290–300. doi: 10.2337/diacare.3.2.290. [DOI] [PubMed] [Google Scholar]
  7. Pickup J. C., Keen H., White M. C., Kohner E. M., Parsons J. A., Alberti K. G. Perfusions sous-cutanées d'insuline chez les diabétiques: résultats cliniques. Journ Annu Diabetol Hotel Dieu. 1980 May;:17–22. [PubMed] [Google Scholar]
  8. Pickup J. C., White M. C., Keen H., Parsons J. A., Alberti K. G. Long-term continuous subcutaneous insulin infusion in diabetics at home. Lancet. 1979 Oct 27;2(8148):870–873. doi: 10.1016/s0140-6736(79)92686-2. [DOI] [PubMed] [Google Scholar]
  9. Raskin P., Pietri A., Unger R. Changes in glucagon levels after four to five weeks of glucoregulation by portable insulin infusion pumps. Diabetes. 1979 Nov;28(11):1033–1035. doi: 10.2337/diab.28.11.1033. [DOI] [PubMed] [Google Scholar]
  10. Tamborlane W. V., Sherwin R. S., Genel M., Felig P. Outpatient treatment of juvenile-onset diabetes with a preprogrammed portable subcutaneous insulin infusion system. Am J Med. 1980 Feb;68(2):190–196. doi: 10.1016/0002-9343(80)90353-8. [DOI] [PubMed] [Google Scholar]
  11. Tamborlane W. V., Sherwin R. S., Genel M., Felig P. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med. 1979 Mar 15;300(11):573–578. doi: 10.1056/NEJM197903153001101. [DOI] [PubMed] [Google Scholar]
  12. Tamborlane W. V., Sherwin R. S., Genel M., Felig P. Restoration of normal lipid and aminoacid metabolism in diabetic patients treated with a portable insulin-infusion pump. Lancet. 1979 Jun 16;1(8129):1258–1261. doi: 10.1016/s0140-6736(79)92226-8. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES